Effect of short- and long-acting 2 -adrenoceptor agonists on pulmonary 2 -adrenoceptor expression in human lung

Author： Nishikawa M.   Mak J.C.W.   Barnes P.J.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.318, Iss.1, 1996-12, pp. : 123-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-acting 2-adrenoceptor agonists: increased risk of death?

By  

Reactions Weekly, Vol. 1, Iss. 1072, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Long-Acting 2-Adrenoceptor Agonists and Exercise-Induced Asthma: Lessons to Guide Us in the Future

By Anderson Sandra D.   Brannan John D.  

Pediatric Drugs, Vol. 6, Iss. 3, 2004-01 ,pp. : 161-175

Adis International

Access to resources Recommend Favorite

Exosites: their current status, and their relevance to the duration of action of long-acting 2 -adrenoceptor agonists

By Coleman R.A.   Johnson M.   Nials A.T.   Vardey C.J.  

Trends in Pharmacological Sciences, Vol. 17, Iss. 9, 1996-09 ,pp. : 324-330

Elsevier

Access to resources Recommend Favorite

Some Pharmacodynamic Aspects on Long-Acting -Adrenoceptor Agonists

By Waldeck B.  

General Pharmacology, Vol. 27, Iss. 4, 1996-06 ,pp. : 575-580

Elsevier

Access to resources Recommend Favorite

Anti-inflammatory effects of a short-acting and a long-acting 2 -adrenoceptor agonist in guinea pig skin

By Teixeira M.M.   Williams T.J.   Hellewell P.G.  

European Journal of Pharmacology, Vol. 272, Iss. 2, 1995-01 ,pp. : 185-193

Elsevier

Access to resources Recommend Favorite